Hepatitis C microelimination among people living with HIV in Taiwan

References

• World Health Organization. Global health sector strategy on viral hepatitis, 2016–2021: towards ending viral hepatitis; [assessed 2022 Mar 23]. Available from: https://apps.who.int/iris/handle/10665/246177?locale-attribute=en&.
   Google Scholar
• Veldt BJ, Heathcote EJ, Wedemeyer H, et al. Sustained virologic response and clinical outcomes in patients with chronic hepatitis C and advanced fibrosis. Ann Intern Med. 2007;147:677–684.
   PubMed Web of Science ®Google Scholar
• Morgan RL, Baack B, Smith BD, et al. Eradication of hepatitis C virus infection and the development of hepatocellular carcinoma: a meta-analysis of observational studies. Ann Intern Med. 2013;158:329–337.
   PubMed Web of Science ®Google Scholar
• Kanwal F, Kramer J, Asch SM, et al. Risk of hepatocellular cancer in HCV patients treated with direct-acting antiviral agents. Gastroenterology. 2017;153:996–1005.e1.
   PubMed Web of Science ®Google Scholar
• Knop V, Hoppe D, Welzel T, et al. Regression of fibrosis and portal hypertension in HCV-associated cirrhosis and sustained virologic response after interferon-free antiviral therapy. J Viral Hepat. 2016;23:994–1002.
   PubMed Web of Science ®Google Scholar
• Hickman M, De Angelis D, Vickerman P, et al. Hepatitis C virus treatment as prevention in people who inject drugs: testing the evidence. Curr Opin Infect Dis. 2015;28:576–582.
   PubMed Web of Science ®Google Scholar
• Hajarizadeh B, Grebely J, Martinello M, et al. Hepatitis C treatment as prevention: evidence, feasibility, and challenges. Lancet Gastroenterol Hepatol. 2016;1:317–327.
   PubMed Web of Science ®Google Scholar
• Hajarizadeh B, Grebely J, Byrne M, et al. Evaluation of hepatitis C treatment-as-prevention within Australian prisons (SToP-C): a prospective cohort study. Lancet Gastroenterol Hepatol. 2021;6:533–546.
   PubMed Web of Science ®Google Scholar
• Shiha G, Soliman R, Mikhail NNH, et al. Reduced incidence of hepatitis C in 9 villages in rural Egypt: progress towards national elimination goals. J Hepatol. 2021;74:303–311.
   PubMed Web of Science ®Google Scholar
• Averhoff F, Shadaker S, Gamkrelidze A, et al. Progress and challenges of a pioneering hepatitis C elimination program in the country of Georgia. J Hepatol. 2020;72:680–687.
   PubMed Web of Science ®Google Scholar
• Matthews GV, Dore GJ. HIV and hepatitis C coinfection. J Gastroenterol Hepatol. 2008;23:1000–1008.
   PubMed Web of Science ®Google Scholar
• Kim AY, Chung RT. Coinfection with HIV-1 and HCV – a one-two punch. Gastroenterology. 2009;137:795–814.
   PubMed Web of Science ®Google Scholar
• Garvey LJ, Cooke GS, Smith C, et al. Decline in hepatitis C virus (HCV) incidence in men who have sex with men living with human immunodeficiency virus: progress to HCV microelimination in the United Kingdom? Clin Infect Dis. 2021;72:233–238.
   PubMed Web of Science ®Google Scholar
• Boerekamps A, van den Berk GE, Lauw FN, et al. Declining hepatitis C virus (HCV) incidence in Dutch human immunodeficiency virus-positive men who have sex with men after unrestricted access to HCV therapy. Clin Infect Dis. 2018;66:1360–1365.
   PubMed Web of Science ®Google Scholar
• Doyle JS, van Santen DK, Iser D, et al. Microelimination of hepatitis C Among people with human immunodeficiency virus coinfection: declining incidence and prevalence accompanying a multicenter treatment scale-up trial. Clin Infect Dis. 2021;73:e2164–e2172.
   PubMed Web of Science ®Google Scholar
• Braun DL, Hampel B, Ledergerber B, et al. A treatment-as-prevention trial to eliminate hepatitis C among men who have sex with men living with human immunodeficiency virus (HIV) in the Swiss HIV cohort study. Clin Infect Dis. 2021;73:e2194–e2202.
   PubMed Web of Science ®Google Scholar
• Kusejko K, Salazar-Vizcaya L, Shah C, et al. Sustained effect on hepatitis C elimination among men who have sex with men in the Swiss HIV cohort study: a systematic re-screening for hepatitis C RNA two years following a nation-wide elimination program. Clin Infect Dis. 2022; [in press]. doi: 10.1093/cid/ciac273.
   Web of Science ®Google Scholar
• Supanan R, Han WM, Harnpariphan W, et al. Brief report: HCV universal test-and-treat with direct acting antivirals for prisoners with or without HIV: a prison health care workers-Led model for HCV microelimination in Thailand. J Acquir Immune Defic Syndr. 2021;88:465–469.
   PubMed Web of Science ®Google Scholar
• Yang T-H, Fang Y-J, Hsu S-J, et al. Microelimination of chronic hepatitis C by universal screening plus direct-acting antivirals for incarcerated persons in Taiwan. Open Forum Infect Dis. 2020;7(8):ofaa301. doi: 10.1093/ofid/ofaa301.
   PubMed Web of Science ®Google Scholar
• Chien R-N, Lu S-N, Pwu R-F, et al. Taiwan accelerates its efforts to eliminate hepatitis C. Glob Heal Med. 2021;3:293–300.
   PubMedGoogle Scholar
• Chen D-S. Taiwan commits to eliminating hepatitis C in 2025. Lancet Infect Dis. 2019;19:466–467.
   PubMed Web of Science ®Google Scholar
• Huang M-H, Sun H-Y, Ho S-Y, et al. Recently acquired hepatitis C virus infection among people living with human immunodeficiency virus at a university hospital in Taiwan. World J Gastroenterol. 2021;27:6277–6289.
   PubMed Web of Science ®Google Scholar
• Li C-W, Yang C-J, Sun H-Y, et al. Changing seroprevalence of hepatitis C virus infection among HIV-positive patients in Taiwan. PLoS One. 2018;13:e0194149.
   PubMed Web of Science ®Google Scholar
• Sun H-Y, Ko W-C, Tsai J-J, et al. Seroprevalence of chronic hepatitis B virus infection among Taiwanese human immunodeficiency virus type 1-positive persons in the era of nationwide hepatitis B vaccination. Am J Gastroenterol. 2009;104:877–884.
   PubMed Web of Science ®Google Scholar
• Taiwan Centers for Disease Control. HIV statistics; 2021; [accessed 2022 Mar 15]. Available from https://www.cdc.gov.tw/Category/Page/rCV9N1rGUz9wNr8lggsh2Q.
   Google Scholar
• Sun H-Y, Chiang C, Huang S-H, et al. Three-stage pooled-plasma HCV RNA testing for the identification of acute HCV infections in At-risk populations. Microbiol Spectr. 2022; [in press]. https://doi.org/10.1128/spectrum.02437-21
   Web of Science ®Google Scholar
• Lesko CR, Bengtson AM. HIV and COVID-19: intersecting epidemics with many unknowns. Am J Epidemiol. 2021;190:10–16.
   PubMed Web of Science ®Google Scholar
• World Health Organization. Disruption in HIV, Hepatitis and STI services due to COVID-19; [accesses 2022 Mar 23]. Available from: https://www.who.int/docs/default-source/hiv-hq/disruption-hiv-hepatitis-sti-services-due-to-covid19.pdf?sfvrsn=5f78b742_8.
   Google Scholar
• Ho S-Y, Su L-H, Sun H-Y, et al. Trends of recent hepatitis C virus infection among HIV-positive men who have sex with men in Taiwan, 2011-2018. EClin Med. 2020;24:100441.
   PubMedGoogle Scholar
• Lambers FAE, Prins M, Thomas X, et al. Alarming incidence of hepatitis C virus re-infection after treatment of sexually acquired acute hepatitis C virus infection in HIV-infected MSM. AIDS. 2011;25:F21–F27.
   PubMed Web of Science ®Google Scholar
• Martin TCS, Rauch A, Salazar-Vizcaya L, et al. Understanding and addressing hepatitis C virus reinfection among men who have sex with men. Infect Dis Clin North Am. 2018;32:395–405.
   PubMed Web of Science ®Google Scholar
• Ingiliz P, Martin TC, Rodger A, et al. HCV reinfection incidence and spontaneous clearance rates in HIV-positive men who have sex with men in Western Europe. J Hepatol. 2017;66:282–287.
   PubMed Web of Science ®Google Scholar
• Martin TCS, Martin NK, Hickman M, et al. Hepatitis C virus reinfection incidence and treatment outcome among HIV-positive MSM. AIDS. 2013;27:2551–2557.
   PubMed Web of Science ®Google Scholar
• Ingiliz P, Wehmeyer MH, Boesecke C, et al. Reinfection with the hepatitis C virus in men who have sex with men after successful treatment with direct-acting antivirals in Germany: current incidence rates, compared with rates during the interferon era. Clin Infect Dis. 2020;71:1248–1254.
   PubMed Web of Science ®Google Scholar
• Hagan H, Jordan AE, Neurer J, et al. Incidence of sexually transmitted hepatitis C virus infection in HIV-positive men who have sex with men. AIDS. 2015;29:2335–2345.
   PubMed Web of Science ®Google Scholar
• Huang M-H, Chang S-Y, Liu C-H, et al. HCV reinfections after viral clearance among HIV-positive patients with recent HCV infection in Taiwan. Liver Int. 2019;39:1860–1867.
   PubMed Web of Science ®Google Scholar
• Cheng C-Y, Ku S-Y, Lin Y-C, et al. Incidence and risk factors of reinfection with HCV after treatment in people living with HIV. Viruses. 2022;14:439.
   PubMed Web of Science ®Google Scholar
• Chen G-J, Sun H-Y, Chang S-Y, et al. Sexually-transmitted hepatitis C virus reinfections among people living with HIV in Taiwan: emerging role of genotype 6. Emerg Microbes Infect. 2022;11:1227–1235.
   PubMed Web of Science ®Google Scholar
• Schlabe S, Rockstroh JK. Advances in the treatment of HIV/HCV coinfection in adults. Expert Opin Pharmacother. 2018;19:49–64.
   PubMed Web of Science ®Google Scholar